Related Experiment Video
Updated: Mar 23, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells
Daniel M Tiago1, Natércia Conceição1, Helena Caiado1
1Centre of Marine Sciences (CCMAR), University of Algarve, Faro, Portugal.
Abstract:
MGP is a protein that was initially associated with the inhibition of calcification in skeleton, soft tissues, and arteries, but more recently also implicated in cancer. In breast cancer, higher levels of MGP mRNA were associated with poor prognosis, but since this deregulation was never demonstrated at the protein level, we postulated the involvement of a post-transcriptional regulatory mechanism. In this work we show that MGP is significantly repressed by miR-155 in breast cancer MCF-7 cells, and concomitantly there is a stimulation of cell proliferation and cell invasiveness. This study brings new insights into the putative involvement of MGP and oncomiR-155 in breast cancer, and may contribute to develop new therapeutic strategies.
Insights
Matrix Gla protein (MGP) is repressed by miR-155 in breast cancer cells, promoting tumor growth and invasiveness. This suggests MGP and miR-155 as potential therapeutic targets for breast cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix Gla protein (MGP) is known for inhibiting calcification but is increasingly linked to cancer.
- Previous studies noted MGP mRNA upregulation in breast cancer correlating with poor prognosis.
- The protein-level evidence for MGP's role in breast cancer and its regulation remained unclear.
Discussion:
- This research demonstrates that miR-155 directly represses MGP expression in breast cancer MCF-7 cells.
- The repression of MGP by miR-155 leads to increased cell proliferation and invasiveness.
- This highlights a post-transcriptional regulatory mechanism involving MGP in breast cancer progression.
Key Insights:
- miR-155 acts as an oncomiR by downregulating MGP in breast cancer.
- MGP downregulation by miR-155 is associated with enhanced breast cancer cell proliferation.
- MGP downregulation by miR-155 is associated with enhanced breast cancer cell invasiveness.
Outlook:
- MGP and miR-155 represent potential biomarkers for breast cancer prognosis.
- Targeting the miR-155/MGP axis could offer novel therapeutic strategies for breast cancer.
- Further investigation into MGP's precise functions in cancer is warranted.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

